v3.24.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   40,361    
Beginning balance at Dec. 31, 2022 $ 542,078 $ 4 $ 772,562 $ (230,488)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]        
Stock-based compensation expense 70,219   70,219  
Release of performance stock units (in shares)   180    
Taxes paid related to net-share settlement of share-based compensation awards (in shares)   (84)    
Taxes paid related to net-share settlement of share-based compensation awards (11,482)   (11,482)  
Stock options exercised (in shares)   1,068    
Stock options exercised 10,054   10,054  
Release of restricted stock units (in shares)   447    
Net income 3,950     3,950
Ending balance (in shares) at Sep. 30, 2023   41,972    
Ending balance at Sep. 30, 2023 614,819 $ 4 841,353 (226,538)
Beginning balance (in shares) at Jun. 30, 2023   41,531    
Beginning balance at Jun. 30, 2023 596,405 $ 4 825,746 (229,345)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]        
Stock-based compensation expense 25,432   25,432  
Release of performance stock units (in shares)   180    
Taxes paid related to net-share settlement of share-based compensation awards (in shares)   (84)    
Taxes paid related to net-share settlement of share-based compensation awards (11,482)   (11,482)  
Stock options exercised (in shares)   152    
Stock options exercised 1,657   1,657  
Release of restricted stock units (in shares)   193    
Net income 2,807     2,807
Ending balance (in shares) at Sep. 30, 2023   41,972    
Ending balance at Sep. 30, 2023 614,819 $ 4 841,353 (226,538)
Beginning balance (in shares) at Dec. 31, 2023   42,526    
Beginning balance at Dec. 31, 2023 655,501 $ 4 869,918 (214,421)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]        
Stock-based compensation expense $ 80,690   80,690  
Stock options exercised (in shares) 802 802    
Stock options exercised $ 11,595   11,595  
Release of restricted stock units (in shares)   616    
Net income 74,667     74,667
Ending balance (in shares) at Sep. 30, 2024   43,944    
Ending balance at Sep. 30, 2024 822,453 $ 4 962,203 (139,754)
Beginning balance (in shares) at Jun. 30, 2024   43,500    
Beginning balance at Jun. 30, 2024 766,944 $ 4 930,054 (163,114)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]        
Stock-based compensation expense 28,959   28,959  
Stock options exercised (in shares)   222    
Stock options exercised 3,190   3,190  
Release of restricted stock units (in shares)   222    
Net income 23,360     23,360
Ending balance (in shares) at Sep. 30, 2024   43,944    
Ending balance at Sep. 30, 2024 $ 822,453 $ 4 $ 962,203 $ (139,754)